Articoli correlati
Immunoterapia
Therapeutic approach reinforced by tarlatamab plus durvalumab and other agents in aggressive cancers.
Articoli correlati
Therapeutic approach reinforced by tarlatamab plus durvalumab and other agents in aggressive cancers.